Therapeutic options in acute severe ulcerative colitis. - Test2 - elhamkhani - TriplyDB

Therapeutic options in acute severe ulcerative colitis.

Therapeutic options in acute severe ulcerative colitis.

http://www.wikidata.org/entity/Q37345935

about

Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN.Genetics of ulcerative colitis.

P2860

Q37827687-BCB053CD-7E8E-477D-BCA0-D02E88C0ACF4 Q37841401-88C9B55D-6549-4DE9-8221-26B39BEB1F94

P2860

Therapeutic options in acute severe ulcerative colitis.

http://www.wikidata.org/entity/Q37345935

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Therapeutic options in acute severe ulcerative colitis.

@en

Therapeutic options in acute severe ulcerative colitis.

@nl

type

label

Therapeutic options in acute severe ulcerative colitis.

@en

Therapeutic options in acute severe ulcerative colitis.

@nl

prefLabel

Therapeutic options in acute severe ulcerative colitis.

@en

Therapeutic options in acute severe ulcerative colitis.

@nl

P1433

Q37345935-58ADDE2F-B30B-48B1-B56C-31B0BC1A212C

P1476

Q37345935-B727382F-870C-4FF3-A6A5-4E03BF968023

P2093

Q37345935-1AB0A661-833C-46C6-85B1-E4F038B64225

Q37345935-B31066A9-86DE-40D0-B34E-9DAD102505CE

Q37345935-B6732413-D11B-4B51-B60F-8B41873F700A

P2860

Q37345935-008329F5-F7F5-42CC-A0F4-C462E3067C6C

Q37345935-070DDDD2-6C87-4EFA-84A6-6B00DFE3BA29

Q37345935-07A6C4B0-E38E-4917-AD74-5CBDC769B24B

Q37345935-088D7460-7B8D-4426-8F05-C6BDF95CC9F6

Q37345935-0B20C351-20D1-4FC8-8CF7-F37725DA9B41

Q37345935-0BB82494-50C3-45EE-9D07-5A70408C99E6

Q37345935-15C0DA04-FA7A-4C78-A2F5-E69421F751E6

Q37345935-1639F3B8-F732-4F3B-913C-93F359C775F3

Q37345935-1803F695-F982-47D7-A677-704E7F17122A

Q37345935-1844C598-3090-47C9-8CF8-4EB522AA770D

P304

Q37345935-5232968A-8228-469D-9757-FB54F429FC31

P31

Q37345935-0C7FBE92-FC42-453C-B4BF-2D71ED686228

P356

Q37345935-0CADD978-8133-464F-A7C3-B823AE92134B

P433

Q37345935-98D10754-82E4-4F62-A092-608E497DA900

P478

Q37345935-90B483D6-29E1-4C61-902B-7D58BA84271C

P577

Q37345935-A42DB805-AC70-48D4-88AE-0FBAF88C414D

P698

Q37345935-865B8A5B-E6F4-4873-AA9F-15AF89079EBC

P356

17474124.2.3.357

P1433

Expert Review of Gastroenterology & Hepatology

P1476

Therapeutic options in acute severe ulcerative colitis.

@en

P2093

Ian Dr Arnott

http://www.w3.org/2001/XMLSchema#string

Jack Satsangi

http://www.w3.org/2001/XMLSchema#string

Nicola C Hare

http://www.w3.org/2001/XMLSchema#string

P2860

Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Infliximab maintenance therapy for fistulizing Crohn's disease

Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease

Infliximab for induction and maintenance therapy for ulcerative colitis

FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics

Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences

Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides.

Interleukin-2 receptor monoclonal antibodies in renal transplantation: meta-analysis of randomised trials.

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.

P304

357-370

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/17474124.2.3.357

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2008-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19072385

http://www.w3.org/2001/XMLSchema#string